Table 2.
Mean fetal blood gas parameters collected from Control and PR fetuses
| Control (n = 8) | Control + VEGF (n = 9) | PR (n = 7) | PR + VEGF (n = 5) | |
|---|---|---|---|---|
| (mmHg) | 21.9 ± 0.9 | 22.2 ± 0.9 | 14.7 ± 0.3† | 15.5 ± 0.6† |
| (mmHg) | 49.6 ± 1.4 | 50.3 ± 1.0 | 49.7 ± 0.8 | 54.3 ± 1.9 |
| (%) | 66.5 ± 5.6 | 62.7 ± 3.0 | 41.8 ± 2.0† | 44.3 ± 5.4† |
| pH | 7.378 ± 0.004 | 7.383 ± 0.009 | 7.374 ± 0.005† | 7.355 ± 0.005† |
| Hb (ml dl‐1) | 8.7 ± 0.6 | 9.6 ± 0.5 | 10.2 ± 0.6 | 9.9 ± 1.5 |
| Hct (%) | 28.4 ± 1.3 | 29.8 ± 1.4 | 31.3 ± 1.9 | 30.7 ± 4.4 |
Data (mean ± SEM) were analysed by two‐way ANOVA for treatment (Control vs. PR) and drug (Saline vs. VEGF). P < 0.05 was considered statistically significant. † P < 0.05 from Control fetuses (i.e. treatment effect).